| Bioactivity | p38-α MAPK-IN-4 (Compound 69) is a selective p38α MAPK inhibitor with an IC50 of 1.5 µM. p38-α MAPK-IN-4 rapidly and strongly prevents the development of mechanical allodynia (MA) in vivo[1]. |
| Name | p38-α MAPK-IN-4 |
| CAS | 2396754-57-5 |
| Formula | C17H13BrN2O |
| Molar Mass | 341.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Visseq A, et al. Pyridin-2(1H)one derivatives: A possible new class of therapeutics for mechanical allodynia. Eur J Med Chem. 2020 Feb 1;187:111917. |
p38-α MAPK-IN-4
CAS: 2396754-57-5 F: C17H13BrN2O W: 341.20
p38-α MAPK-IN-4 (Compound 69) is a selective p38α MAPK inhibitor with an IC50 of 1.5 µM. p38-α MAPK-IN-4 rapidly and
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.